Extra assay results
Figure S1. The ability of 3 M compound 4 to inhibit platelet activation in response to 5 M SFLLRN-NH 2 , 0.2 M PMA, 100 M AYPGKF, 1 M U46619, or 10 g/ml collagen was monitored using a P-selectin surface expression assay. Only inhibition of the PAR1 agonist SFLLRN-NH 2 was observed. Figure S2 . The ability of compound 4 to inhibit platelet activation induced by 100 mU/ml thrombin was monitored using a P-selectin surface expression assay. 
ML161 (M)
Compound 4 (M) Figure S3 . Aggregation of washed platelets was initiated by either SFLLRN-NH 2 (5 M), thrombin (100 mU/ml), AYPGFK (100 M), thromboxane (1 M), or ADP (10 M). Platelet agonists were added following incubation with DMSO (black tracings) or 3 M ML161 (red tracings).
Assay protocols P-Selectin Expression Assay.
Blood from healthy donors who had not ingested aspirin in the 2 weeks prior to donation was collected by venipuncture into 0.4% sodium citrate. Approval for these studies was obtained from the Beth Israel Deaconess Medical Center institutional review board. Informed consent was provided according to the Declaration of Helsinki. Citrateanticoagulated blood was centrifuged at 200g for 20 minutes to prepare platelet-rich plasma. Washed platelets were subsequently prepared from platelet-rich plasma by centrifugation at 1,000g in the presence of 0.15 M PGE 1 . For analysis of P-selectin expression, 20 µL washed platelets (0.5-1 x 10 8 /mL) were incubated with the indicated agonists. Platelet activation was measured by P-selectin surface expression using PE-antihuman P-selectin (BD) and flow cytometry.
1 Results are expressed as percent inhibition of P-selectin surface expression.
Platelet Aggregation. Aggregation of washed platelets was initiated by the indicated concentrations of agonists and measured using a ChronoLog 680 Aggregation System as described previously. 
Preparation of key compounds General Details
All reagents and solvents were purchased from commercial vendors and used as received. NMR spectra were recorded on a Bruker 300 MHz or Varian UNITY INOVA 500 MHz spectrometer as indicated. Proton and carbon chemical shifts are reported in parts per million (ppm;δ) relative to tetramethylsilane, CDCl3 solvent, or d6-DMSO ( 1 H δ 0, 13C δ 77.0, or 13 C δ 39.5, respectively). NMR data are reported as follows: chemical shifts, multiplicity (app = apparent, obs = obscured, br = broad, s = singlet, d = doublet, t = triplet, sept = septet, m = multiplet, comp = complex overlapping signals); coupling constant(s) in Hz; integration. Unless otherwise indicated, NMR data were collected at 25°C. Flash chromatography was performed using 40-60 µm Silica Gel (60 Å mesh) on a Teledyne Isco Combiflash Rf system. Tandem liquid chromatography/mass spectrometry (LCMS) was performed on a Waters 2795 separations module and Waters 3100 mass detector. Analytical thin layer chromatography (TLC) was performed on EM Reagent 0.25 mm silica gel 60-F plates. Visualization was accomplished with UV light and aqueous potassium permanganate (KMnO4) stain followed by heating. Highresolution mass spectra were obtained at the MIT Mass Spectrometry Facility with a Bruker Daltonics APEXIV 4.7 Tesla Fourier Transform Ion Cyclotron Resonance mass spectrometer. Compound purity and identity were determined by UPLC-MS (Waters, Milford, MA). Purity was measured by UV absorbance at 210 nm. Identity was determined on a SQ mass spectrometer by positive electrospray ionization. Mobile Phase A consisted of either 0.1% ammonium hydroxide or 0.1% trifluoroacetic acid in water, while mobile Phase B consisted of the same additives in acetonitrile. The gradient ran from 5% to 95% mobile Phase B over 0.8 minutes at 0.45 mL/min. An Acquity BEH C18, 1.7 µm, 1.0 x 50 mm column was used with column temperature maintained at 65 °C. Compounds were dissolved in DMSO at a nominal concentration of 1 mg/mL, and 0.25 µL of this solution was injected.
Plasma Stability
Plasma stability was determined at 37 °C for 5 hours in both human and mouse plasma. Each compound was prepared in duplicate at 5 µM in plasma diluted 50/50 (v/v) with PBS pH 7.4 (0.95% acetonitrile, 0.05% DMSO). The compounds were incubated at 37 °C for 5 hours with a 250 rpm orbital shake with time points taken at 0 and 5 hours. The samples were analyzed by UPLC-MS (Waters, Milford, MA) with compounds detected by SIR detection on a single quadrupole mass spectrometer.
Compounds 1-36, 44, 58, and 65 were prepared according to (or analogous to) Representative Synthesis 1; compounds 40, 42, 43, 45-50, 55-57, 59, 60, and 66-68 were prepared according (or analogous to) Representative Synthesis 2; compounds 37-39, 41, 51-54, and 61-64, and 69 were obtained from commercial sources. All tested compounds were at least 90% pure (almost exclusively >95% pure) by LC-MS analysis (λ = 210 nm).
Details for the preparation of compounds 4 (ML161), 66, and 68 are provided below.
N-(3-nitrophenyl)butyramide
3-Nitroaniline (6.00 g, 43.4 mmol) was sealed in a flask with stir bar under nitrogen and dissolved with dichloromethane (145 mL). The solution was cooled on ice before (i-Pr) 2 NEt (8.35 ml, 47.8 mmol) and butyryl chloride (5.00 ml, 47.8 mmol) were added. The flask was removed from the ice and stirred for 16 h. The reaction was then diluted with dichloromethane and aqueous 1 M HCl, the layers were separated, and the combined organics were washed again with 1 M aqueous HCl, then twice with half-saturated aq. NaHCO 3 , then brine. The organic phase was dried over MgSO 4 , filtered, and concentrated, yielding a yellow oil (9.04 g, 100%). 
N-(3-aminophenyl)butyramide
A solution of N-(3-nitrophenyl)butyramide (8.60 g, 41.3 mmol) in methanol (207 mL) was divided between two 500 mL flasks with stir bars. Each flask was flushed well with nitrogen, then 5% palladium on carbon (4.40 g, 2.065 mmol) was added, half to each flask. A 3-way adapter with a large hydrogen-filled balloon was attached to each flask, and the reactions were evacuated and back-filled with hydrogen five times, while stirring vigorously. The reactions were then stirred for 16 h, then filtered through a funnel packed with Celite. The filter cake was washed with methanol, and the filtrate was concentrated, redissolved with dichloromethane, then purified by column chromatography (EtOAc/hexanes gradient) to yield a white solid after precipitating from hexanes (5.87 g, 80%). 
2-bromo-N-(3-butyramidophenyl)benzamide (ML161, 4)
2-Bromobenzoic acid (259 mg, 1.29 mmol) was sealed in a flask with stir bar under nitrogen, then dissolved with dichloromethane (7.5 mL) and cooled on ice. Oxalyl chloride (113 µL, 1.29 mmol) and N,N-dimethylformamide (4 µL, 0.06 mmol) were added, then the reaction was removed from the ice bath and stirred for 3 h with a vent to an oil bubbler. N-(3-Aminophenyl)butyramide (200 mg, 1.12 mmol) was then added, followed by pyridine (209 µL, 2.58 mmol). After 18 h, LC-MS analysis showed complete consumption of the amine reactant. The reaction was diluted with ethyl acetate (40 mL) and 1 M aqueous HCl (40 mL), then the layers were separated and the organic phase was washed again with aqueous HCl, then twice with half-saturated aqueous NaHCO 3 , then brine. The organics were dried over Na 2 SO 4 , filtered, and concentrated to a colorless oil. The oil was redissolved with dichloromethane, then hexane was added to induce the precipitation of an amorphous solid. The suspension was concentrated and dried under hi-vacuum to yield the title compound (382 mg, 94%).
1 H NMR (300 MHz, CDCl 3 ): δ 7.95 (s, 1H), 7.75 (s, 1H), 7.62 (app t, J = 7.6 Hz, 2H), 7.37 (comp, 6H), 2.31 (t, J = 7.4 Hz, 2H), 1.74 (m, 2H), 1.00 (t, J = 7.4 Hz, 3H).
13
C NMR (75 MHz, CDCl 3 ): δ 171. 3, 165.6, 138.8, 138.1, 137.7, 133.6, 131.6, 129.7, 127.8, 119.3, 116.0, 115.5, 111.1, 39.7, 19.0, 13.7 
Representative Synthesis 2 (Scheme 2 in manuscript)

2-bromo-N-(3-nitrophenyl)benzamide
2-Bromobenzoic acid (5.02 g, 25.0 mmol) was sealed in a 250 mL flask with stir bar under nitrogen. Dichloromethane (72 mL) was then added and the solution was cooled on ice. Oxalyl chloride (2.19 ml, 25.0 mmol) and N,N-dimethylformamide (17 µL, 0.22 mmol) were added, and the reaction was removed from the ice bath and the resulting suspension was stirred for 20 h with a vent to an oil bubbler. After this time, the pale yellow solution was cooled on ice, then pyridine (4.04 ml, 50.0 mmol) and 3-nitroaniline (3.00 g, 21.7 mmol) were added. The reaction was then removed from the ice bath, and a water condenser was attached to the flask.
The reaction was heated in an oil bath at 45 °C, and after 1 h LC-MS analysis showed the reaction to be complete. The reaction was diluted with ethyl acetate (250 mL) and 1 M aqueous HCl (100 mL), then the layers were separated and the organic phase was washed again with aqueous HCl, then twice with half-saturated aqueous NaHCO 3 , then brine. The organics were dried over Na 2 SO 4 , filtered, and concentrated to a yellow solid, which was dried and pulverized several times, yielding the title compound (6.89 g, 99%).
1 H NMR (300 MHz, CDCl 3 ): δ 8.49 (s, 1H), 8.19-7.85 (m, 3H), 7.67 (app t, J = 6.8 Hz, 2H), 7.57 (app t, J = 8.2 Hz, 1H), 7.45 (app t, J = 7.4 Hz, 2H). MS (ESI + ) (M + H): 321.01.
N-(3-aminophenyl)-2-bromobenzamide
2-Bromo-N-(3-nitrophenyl)benzamide (6.89 g, 21.5 mmol) was added to a 1 L flask with stir bar and dissolved with THF (143 mL). Sodium dithionite (37.4 g, 215 mmol) (aka sodium hydrosulfite) was added to a separate flask and dissolved with water (143 mL). The resulting cloudy solution was added to the solution of substrate, and the flask was sealed and flushed with nitrogen, then stirred vigorously for 16 h with a vent line to an oil bubbler. After this time LC-MS analysis showed complete conversion to a mixture of the desired product plus its N-sulfate. To hydrolyze the sulfated material, saturated aqueous ammonium chloride (30 mL) was added, and the mixture was refluxed for 4 h. The layers were then separated, and the aqueous layer was extracted twice with ethyl acetate. The combined organics were washed with brine, then dried over Na 2 SO 4 , filtered, and concentrated. The crude material was then dissolved with dichloromethane and ethyl acetate, leaving an insoluble gum behind. The solution was purified by column chromatography (EtOAc/hexanes gradient), to yield the title compound as a pale yellow solid (4.10 g, 66%), which was used without further purification in the subsequent reaction. MS (ESI + ) (M + H): 291.96.
2-bromo-N-(3-(butylamino)phenyl)benzamide (66)
N-(3-Aminophenyl)-2-bromobenzamide (100 mg, 0.34 mmol) was added to a 10 mL vial with stir bar and dissolved with 1,2-dichloroethane (1.7 mL). Butyraldehyde (46 µL, 0.52 mmol) was added by syringe, followed by sodium triacetoxyborohydride (182 mg, 0.86 mmol). The reaction was stirred for 2 h, after which time LC-MS analysis showed a mixture of mono-and dialkylated material, with little or no aniline starting material remaining. The reaction was quenched by adding aqueous NaHCO 3 and stirring well until bubbling ceased. The crude mixture was diluted with ethyl acetate and water, the layers were separated, then the organic phase was washed again with aq. NaHCO 3 , then brine. The combined organics were dried over Na 2 SO 4 , filtered, and concentrated to a pale yellow oil, then purified by column chromatography (EtOAc/hexanes gradient) to yield a pink oil. This was redissolved with ether/dichloromethane, then the HCl salt of the desired product was formed by adding excess 2 M HCl in ether. The supernatant was removed from the resulting solid, which was subsequently pulverized and washed three times with ether (~1 mL), then dried. The title compound (HCl salt) was obtained as an off-white solid (41 mg, 33% 
2-bromo-N-(3-(3-methylbutanamido)phenyl)benzamide (68)
N-(3-Aminophenyl)-2-bromobenzamide (50 mg, 0.17 mmol), dichloromethane (1.7 mL), pyridine (17 µL, 0.21 mmol), and isovaleryl chloride (25 µL, 0.21 mmol) were added to a vial with stir bar and stirred for 20 h. The reaction was then diluted with ethyl acetate, then the combined organics were washed with 1 M aqueous HCl, then half-saturated aqueous NaHCO 3 , then brine. The crude solution was dried over Na 2 SO 4 , filtered, and concentrated to a colorless oil, then purified by column chromatography (EtOAc/hexanes gradient) after dry-loading on SiO 2 . The title compound was obtained as a white solid (53 mg, 82%).
1 H NMR (300 MHz, DMSO) δ 10.57-10.40 (s, 1H), 9.91 (s, 1H), 8.07 (s, 1H), 7.71 (dd, J = 0.9, 7.8, 1H), 7.58-7.45 (m, 2H), 7.40 (m, 2H), 7.32 (dm, J = 8.5, 1H), 7.23 (app t, J = 8.0, 1H), 2.19 (d, J = 6.8, 2H), 2.14 -1.98 (sept, J = 6.5 Hz, 1H), 0.95 (d, J = 6.5 Hz, 6H 
